{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T12:42:35Z","timestamp":1762605755753,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.vhri.2025.101096","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T13:12:11Z","timestamp":1741612331000},"page":"101096","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Economic and Disease Burden of Multiple Sclerosis in Colombia"],"prefix":"10.1016","volume":"47","author":[{"given":"Ana","family":"Lozano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Camilo","family":"Guti\u00e9rrez-Clavijo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Carlo","family":"Pineda-Lozano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sim\u00f3n","family":"C\u00e1rdenas-Robledo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Casallas-Vanegas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson J.","family":"Alvis-Zakzuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.vhri.2025.101096_bib1","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028928","article-title":"Clinical course of multiple sclerosis","volume":"8","author":"Klineova","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"4","key":"10.1016\/j.vhri.2025.101096_bib2","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1177\/0269215517730670","article-title":"The impact of self-perceived limitations, stigma and sense of coherence on quality of life in multiple sclerosis patients: results of a cross-sectional study","volume":"32","author":"Broersma","year":"2018","journal-title":"Clin Rehabil"},{"issue":"suppl 4","key":"10.1016\/j.vhri.2025.101096_bib3","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1016\/S0035-3787(09)72123-X","article-title":"Quality of life in multiple sclerosis. Article in French","volume":"165","author":"Clavelou","year":"2009","journal-title":"Rev Neurol (Paris)"},{"issue":"14","key":"10.1016\/j.vhri.2025.101096_bib4","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS","volume":"26","author":"Walton","year":"2020","journal-title":"Mult Scler"},{"year":"2018","series-title":"Resoluci\u00f3n 5265 de 2018. Listado Enferm Hu\u00e9rfanas. 26","key":"10.1016\/j.vhri.2025.101096_bib6"},{"issue":"6","key":"10.1016\/j.vhri.2025.101096_bib7","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1177\/1352458509103300","article-title":"Neurological disability, psychological distress, and health-related quality of life in MS patients within the first three years after diagnosis","volume":"15","author":"Kern","year":"2009","journal-title":"Mult Scler"},{"issue":"3","key":"10.1016\/j.vhri.2025.101096_bib8","doi-asserted-by":"crossref","first-page":"226","DOI":"10.22267\/rus.192103.159","article-title":"Calidad de vida en pacientes con esclerosis m\u00faltiple atendidos en una instituci\u00f3n de salud de Medell\u00edn, Colombia","volume":"21","author":"Orozco-Gonz\u00e1lez","year":"2019","journal-title":"Univ Salud"},{"key":"10.1016\/j.vhri.2025.101096_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102162","article-title":"A\u00a0literature review of cost-of-illness studies on the economic burden of multiple sclerosis","volume":"43","author":"Paz-Zulueta","year":"2020","journal-title":"Mult Scler Relat Disord"},{"issue":"7","key":"10.1016\/j.vhri.2025.101096_bib10","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s40273-021-01032-7","article-title":"Economic burden of multiple sclerosis in low- and middle-income countries: a systematic review","volume":"39","author":"Dahham","year":"2021","journal-title":"Pharmacoeconomics"},{"issue":"5","key":"10.1016\/j.vhri.2025.101096_bib11","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1016\/j.jval.2011.05.023","article-title":"Costos de la esclerosis m\u00faltiple en Colombia","volume":"14","author":"Romero","year":"2011","journal-title":"Value Heal"},{"issue":"4","key":"10.1016\/j.vhri.2025.101096_bib12","doi-asserted-by":"crossref","first-page":"385","DOI":"10.22379\/2422402256","article-title":"Estado actual de la esclerosis m\u00faltiple en Colombia","volume":"31","author":"Jim\u00e9nez","year":"2015","journal-title":"Acta Neurol Colomb"},{"issue":"13","key":"10.1016\/j.vhri.2025.101096_bib13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.vhri.2017.12.001","article-title":"Health care cost for multiple sclerosis: the case of a health insurer in Colombia","volume":"17","author":"Mu\u00f1oz-Galindo","year":"2018","journal-title":"Value Heal Reg Issues"},{"issue":"10258","key":"10.1016\/j.vhri.2025.101096_bib15","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Abbafati","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vhri.2025.101096_bib17","doi-asserted-by":"crossref","first-page":"385","DOI":"10.22379\/2422402256","article-title":"Estado actual de la esclerosis m\u00faltiple en Colombia","volume":"31","author":"Jim\u00e9nez-P\u00e9rez","year":"2015","journal-title":"Acta Neurol Colomb"},{"issue":"8","key":"10.1016\/j.vhri.2025.101096_bib19","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1177\/1352458517694432","article-title":"New insights into the burden and costs of multiple sclerosis in Europe","volume":"23","author":"Kobelt","year":"2017","journal-title":"Mult Scler"},{"key":"10.1016\/j.vhri.2025.101096_bib20","article-title":"Manual para la elaboraci\u00f3n de evaluaciones econ\u00f3micas en salud","author":"Mareno","year":"2014","journal-title":"Instituto de Evaluaci\u00f3n Tecnol\u00f3gica en Salud"},{"key":"10.1016\/j.vhri.2025.101096_bib23","series-title":"Bioestad\u00edstica Amigable","first-page":"202","article-title":"Estimaci\u00f3n del tama\u00f1o d euna muestra para una media","author":"Mart\u00ednez-Gonzalez","year":"2014"},{"issue":"2","key":"10.1016\/j.vhri.2025.101096_bib24","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.vhri.2025.101096_bib25","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0212-6567(01)78795-1","article-title":"Los costes en la evaluaci\u00f3n econ\u00f3mica de tecnolog\u00edas sanitarias","volume":"27","author":"Puig-Junoy","year":"2001","journal-title":"Aten Prim"},{"key":"10.1016\/j.vhri.2025.101096_bib26","series-title":"Noveno Informe T\u00e9cnico ONS. Consecuencias del Conflicto Armado en La Salud en Colombia","first-page":"240","article-title":"Carga econ\u00f3mica de las enfermedades trasmitidas por vectores en zonas de conflicto","author":"Castillo-Rodr\u00edguez","year":"2017"},{"key":"10.1016\/j.vhri.2025.101096_bib28","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1474-4422(18)30443-5","article-title":"Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the global burden of disease study 2016","volume":"18","year":"2019","journal-title":"Lancet Neurol"},{"issue":"10258","key":"10.1016\/j.vhri.2025.101096_bib29","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","article-title":"Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Abbafati","year":"2020","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.vhri.2025.101096_bib30","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1136\/jnnp-2017-315907","article-title":"Excess mortality among patients with multiple sclerosis in Denmark has dropped significantly over the past six decades: a population based study","volume":"88","author":"Koch-Henriksen","year":"2017","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"11","key":"10.1016\/j.vhri.2025.101096_bib31","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1177\/1352458519861270","article-title":"Change in multiple sclerosis prevalence over time in Australia 2010-2017 utilising disease-modifying therapy prescription data","volume":"26","author":"Campbell","year":"2020","journal-title":"Mult Scler"},{"issue":"9","key":"10.1016\/j.vhri.2025.101096_bib32","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1093\/brain\/awt220","article-title":"Epidemiology in multiple sclerosis: a pilgrim\u2019s progress","volume":"136","author":"Kurtzke","year":"2013","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.vhri.2025.101096_bib33","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S1474-4422(10)70064-8","article-title":"The changing demographic pattern of multiple sclerosis epidemiology","volume":"9","author":"Koch-Henriksen","year":"2010","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.vhri.2025.101096_bib34","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1212\/WNL.0000000000004207","article-title":"Breastfeeding, ovulatory years, and risk of multiple sclerosis","volume":"89","author":"Langer-Gould","year":"2017","journal-title":"Neurology"},{"issue":"22","key":"10.1016\/j.vhri.2025.101096_bib35","doi-asserted-by":"crossref","first-page":"e1954","DOI":"10.1212\/WNL.0000000000005612","article-title":"Incidence of MS has increased markedly over six decades in Denmark particularly with late onset and in women","volume":"90","author":"Koch-Henriksen","year":"2018","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.vhri.2025.101096_bib36","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1080\/01616412.2020.1866374","article-title":"Delayed diagnosis of multiple sclerosis in a low prevalence country","volume":"43","author":"C\u00e1rdenas-Robledo","year":"2021","journal-title":"Neurol Res"},{"issue":"1","key":"10.1016\/j.vhri.2025.101096_bib37","first-page":"49","article-title":"Epidemiolog\u00eda de diabetes mellitus tipo 2 en la poblaci\u00f3n colombiana y factores de riesgo que predisponen a la amputaci\u00f3n de miembros inferiores. Revisi\u00f3n de la literatura","volume":"4","author":"Ortegate","year":"2018","journal-title":"Salut Sci Spiritus"},{"issue":"5","key":"10.1016\/j.vhri.2025.101096_bib39","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2165\/11532230-000000000-00000","article-title":"Economic burden of multiple sclerosis: a systematic review of the literature","volume":"28","author":"Naci","year":"2010","journal-title":"Pharmacoeconomics"},{"issue":"suppl 1","key":"10.1016\/j.vhri.2025.101096_bib41","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.msard.2016.07.003","article-title":"Brain health: time matters in multiple sclerosis","volume":"9","author":"Giovannoni","year":"2016","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"10.1016\/j.vhri.2025.101096_bib44","first-page":"55","article-title":"Cost-of-illness study of type 2 diabetes mellitus in Colombia","volume":"26","author":"Gonz\u00e1lez","year":"2009","journal-title":"Pan Am J Public Heal"},{"issue":"1","key":"10.1016\/j.vhri.2025.101096_bib45","first-page":"2015","article-title":"Carga econ\u00f3mica de la Enfermedad Renal Cr\u00f3nica en Colombia","volume":"35","author":"Zakzuk","year":"2019","journal-title":"Salud Uninorte"},{"key":"10.1016\/j.vhri.2025.101096_bib46","article-title":"La Carga Econ\u00f3mica de la Enfermedad de Gaucher y Fabry en Colombia","author":"Pinto Mas\u00eds","year":"2008","journal-title":"Javeriana"},{"year":"2021","series-title":"Determinantes Sociales del Gasto Catastr\u00f3fico en Salud En Colombia: un An\u00e1lisis Multinivel","author":"Ram\u00edrez","key":"10.1016\/j.vhri.2025.101096_bib47"},{"issue":"2","key":"10.1016\/j.vhri.2025.101096_bib48","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0167-6296(94)00044-5","article-title":"The friction cost method for measuring indirect costs of disease","volume":"14","author":"Koopmanschap","year":"1995","journal-title":"J\u00a0Health Econ"},{"key":"10.1016\/j.vhri.2025.101096_bib49","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.vhri.2023.02.008","article-title":"Cost-utility analysis comparing ocrelizumab versus rituximab in the treatment of relapsing-remitting multiple\u00a0sclerosis: the Colombian perspective","volume":"36","author":"Navarro","year":"2023","journal-title":"Value Heal Reg Issues"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109925000214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109925000214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T12:34:22Z","timestamp":1762605262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109925000214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":38,"alternative-id":["S2212109925000214"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2025.101096","relation":{},"ISSN":["2212-1099"],"issn-type":[{"type":"print","value":"2212-1099"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Economic and Disease Burden of Multiple Sclerosis in Colombia","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2025.101096","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of International Society for Pharmacoeconomics and Outcomes Research, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101096"}}